The stock of Silexion Therapeutics Corp (NASDAQ: SLXN) has increased by 4.07 when compared to last closing price of 0.31.Despite this, the company has seen a gain of 41.47% in its stock price over the last five trading days. globenewswire.com reported 2024-11-22 that Trading on split-adjusted basis will begin at market open on November 29, 2024. This adjustment is expected to help Silexion comply with NASDAQ requirements, enhance its market position, and support its strategic growth initiatives Trading on split-adjusted basis will begin at market open on November 29, 2024. This adjustment is expected to help Silexion comply with NASDAQ requirements, enhance its market position, and support its strategic growth initiatives
Is It Worth Investing in Silexion Therapeutics Corp (NASDAQ: SLXN) Right Now?
The 36-month beta value for SLXN is also noteworthy at -0.07. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SLXN is 2.18M, and at present, short sellers hold a 35.22% of that float. The average trading volume of SLXN on November 27, 2024 was 5.90M shares.
SLXN’s Market Performance
The stock of Silexion Therapeutics Corp (SLXN) has seen a 41.47% increase in the past week, with a 8.47% rise in the past month, and a -78.23% fall in the past quarter. The volatility ratio for the week is 33.80%, and the volatility levels for the past 30 days are at 16.72% for SLXN. The simple moving average for the last 20 days is 18.66% for SLXN’s stock, with a simple moving average of -95.58% for the last 200 days.
SLXN Trading at -17.83% from the 50-Day Moving Average
After a stumble in the market that brought SLXN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.64% of loss for the given period.
Volatility was left at 16.72%, however, over the last 30 days, the volatility rate increased by 33.80%, as shares surge +8.18% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -66.61% lower at present.
During the last 5 trading sessions, SLXN rose by +41.47%, in comparison to the 20-day moving average, which settled at $0.2697. In addition, Silexion Therapeutics Corp saw -97.05% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SLXN
Equity return is now at value -3.78, with -3.13 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.75.
Conclusion
In summary, Silexion Therapeutics Corp (SLXN) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
